The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis

Immunobiology

Volumn 218, Issue 3, 2013, Pages 311-316

  Toldi, Gergely ^a   Bajnok, Anna ^a   Dobi, Diána ^b   Kaposi, Ambrus ^a   Kovács, László ^b   Vásárhelyi, Barna ^a   Balog, Attila ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Calcium influx; IKCa1; Kv1.3; Lymphocyte activation; Rheumatoid arthritis

Indexed keywords

CALCIUM; CD4 ANTIGEN; CD8 ANTIGEN; POTASSIUM CHANNEL; POTASSIUM CHANNEL IKCA1; POTASSIUM CHANNEL KV1.3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SENSITIVITY ANALYSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADULT; ARTHRITIS, RHEUMATOID; CALCIUM SIGNALING; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; KV1.3 POTASSIUM CHANNEL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; POTASSIUM CHANNEL BLOCKERS; SCORPION VENOMS; TH1 CELLS; TH2 CELLS;

EID: 84873113728     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.013     Document Type: Article

References (20)

1. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., Birnbaum N.S., Burmester G.R., Bykerk V.P., Cohen M.D., Combe B., Costenbader K.H., Dougados M., Emery P., Ferraccioli G., Hazes J.M., Hobbs K., Huizinga T.W., Kavanaugh A., Kay J., Kvien T.K., Laing T., Mease P., Ménard H.A., Moreland L.W., Naden R.L., Pincus T., Smolen J.S., Stanislawska-Biernat E., Symmons D., Tak P.P., Upchurch K.S., Vencovský J., Wolfe F., Hawker G. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010, 62:2569-2581.
2. Beeton C., Wulff H., Barbaria J., Clot-Faybesse O., Pennington M., Bernard D., Cahalan M.D., Chandy K.G., Béraud E. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13942-13947.
3. Beeton C., Wulff H., Standifer N.E., Azam P., Mullen K.M., Pennington M.W., Kolski-Andreaco A., Wei E., Grino A., Counts D.R., Wang P.H., LeeHealey C.J., S Andrews B., Sankaranarayanan A., Homerick D., Roeck W.W., Tehranzadeh J., Stanhope K.L., Zimin P., Havel P.J., Griffey S., Knaus H.G., Nepom G.T., Gutman G.A., Calabresi P.A., Chandy K.G. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17414-17419.
4. Bucht A., Larsson P., Weisbrot L., Thorne C., Pisa P., Smedegård G., Keystone E.C., Grönberg A. Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGFbeta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin. Exp. Immunol. 1996, 103:357-367.
5. Buntinx M., Ameloot M., Steels P., Janssen P., Medaer R., Geusens P., Raus J., Stinissen P. Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?. J. Neuroimmunol. 2002, 124:70-82.
6. Dolhain R., ter Haar N.T., Hoefakker S., Tak P.P., de Ley M., Claassen E., Breedveld F.C., Miltenburg A.M. Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane compared with synovium of patients with osteoarthritis. Br. J. Rheumatol. 1996, 35:24-32.
7. Dolmetsch R.E., Xu K., Lewis R.S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998, 392:933-936.
8. 2+ clearance distinguish Th1 and Th2 lymphocytes. J. Immunol. 2000, 164:1153-1160.
9. Hu L., Pennington M., Jiang Q., Whartenby K.A., Calabresi P.A. Characterization of the functional properties of the voltage-gated potassium channel Kv1. 3 in human CD4+ T lymphocytes. J. Immunol. 2007, 179:4563-4570.
10. Kaposi A.S., Veress G., Vásárhelyi B., Macardle P., Bailey S., Tulassay T., Treszl A. Cytometry-acquired calcium-flux data analysis in activated lymphocytes. Cytometry A 2008, 73:246-253.
11. Nagy G., Clark J.M., Buzas E., Gorman C., Pasztoi M., Koncz A., Falus A., Cope A.P. Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. Immunol. Lett. 2008, 118:55-58.
12. Panyi G. Biophysical and pharmacological aspects of K+ channels in T lymphocytes. Eur. Biophys. J. 2005, 34:515-529.
13. Panyi G., Possani L.D., Rodríguez de la Vega R.C., Gáspár R., Varga Z. K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. Curr. Pharm. Des. 2006, 18:2199-2220.
14. Szalay B., Mészáros G., Cseh á., ács L., Deák M., Kovács L., Vásárhelyi B., Balog A. Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy. Clin. Dev. Immunol. 2012, 808724.
15. Toldi G., Folyovich A., Simon Z., Zsiga K., Kaposi A., Mészáros G., Tulassay T., Vásárhelyi B. Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon beta. J. Neuroimmunol. 2011, 237:80-86.
16. Toldi G., Kaposi A., Zsembery á., Treszl A., Tulassay T., Vásárhelyi B. Human Th1 and Th2 lymphocytes are distinguished by calcium flux regulation during the first ten minutes of lymphocyte activation. Immunobiology 2012, 217:37-43.
17. van der Graaff W.L., Prins A.P., Niers T.M., Dijkmans B.A., van Lier R.A. Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology (Oxford) 1999, 38:214-220.
18. 2+ signaling. Cell Calcium 1995, 17:287-300.
19. Wulff H., Calabresi P.A., Allie R., Yun S., Pennington M., Beeton C., Chandy K.G. The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS. J. Clin. Invest. 2003, 111:1703-1713.
20. Yang P.T., Kasai H., Zhao L.J., Xiao W.G., Tanabe F., Ito M. Increased CCR4 expression on circulating CD4+ T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Immunol. 2004, 138:342-347.